Ejaculation
11
0
0
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
9.1%
1 terminated out of 11 trials
90.9%
+4.4% vs benchmark
36%
4 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (11)
Exploration of Ejaculation Changing Mechanism After Surgery for Benign Prostatic Hyperplasia
A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin
An Observational Study of Men With Premature Ejaculation Who Are Treated With Dapoxetine Hydrochloride or Alternate Care Defined as Any Treatment Other Than Dapoxetine Hydrochloride
Assessment of Efficacy and Safety of UK-390,957 in Men With Premature Ejaculation
Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation
Assessment Of Safety Of UK-390,957
Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation
A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.
An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation